<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T20:40:28Z</responseDate>
  <request identifier="oai:figshare.com:article/31832125" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/31832125</identifier>
        <datestamp>2026-09-18T03:18:11Z</datestamp>
        <setSpec>category_24295</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Integration of scRNA-seq and scATAC-seq revealed the role of lncRNA &lt;i&gt;RP11-661C8.2&lt;/i&gt; by promoting EMT in clear cell renal cell carcinoma</dc:title>
          <dc:creator>Zhenyuan Yu (6698111)</dc:creator>
          <dc:subject>Epigenetics (incl. genome methylation and epigenomics)</dc:subject>
          <dc:subject>scRNA-seq and snATAC-seq integration</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;Long noncoding RNAs (lncRNAs) play an important role in tumor progression. However, most of the previously discovered lncRNAs that promote or inhibit tumor progression were derived from bulk RNA-seq results. Data from single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) in clear cell renal cell carcinoma (ccRCC) were integrated to precisely identify the lncRNAs that regulate tumor progression in ccRCC. The scRNA-seq data of 23 ccRCC samples and the scATAC-seq data of 19 samples were analysed, capturing the transcriptome of 121,106 cells an&lt;a href="" target="_blank"&gt;d the &lt;/a&gt;epigenetic features of 61,693 cells, respectively. Results showed that lncRNA &lt;i&gt;RP11-661C8.2&lt;/i&gt; was associated with significant chromatin accessibility in ccRCC tumor cells by scATAC-seq. Subsequently, integrated scRNA-seq analysis and functional experiments &lt;i&gt;in vitro and in vivo&lt;/i&gt; confirmed the role of &lt;i&gt;RP11-661C8.2&lt;/i&gt; in promoting the invasion, migration and &lt;a href="" target="_blank"&gt;epithelial-mesenchymal transition&lt;/a&gt; (EMT) of ccRCC cells. In addition, &lt;i&gt;RP11-661C8.2&lt;/i&gt; played a role in up-regulating &lt;i&gt;ITGAV&lt;/i&gt; and activating the PI3K/AKT signaling pathway, which may be the potential mechanism of promoting the EMT in ccRCC cells. This study identified the role of&lt;i&gt; RP11-661C8.2&lt;/i&gt; in ccRCC, which provided new reference basis and potential intervention targets for ccRCC.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T03:18:11Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.31832125.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Integration_of_scRNA-seq_and_scATAC-seq_revealed_the_role_of_lncRNA_i_RP11-661C8_2_i_by_promoting_EMT_in_clear_cell_renal_cell_carcinoma/31832125</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
